STAR PHARMACEUTICALS LIMITED

Active Harrow

Manufacture of basic pharmaceutical products

0 employees website.com
Manufacture of basic pharmaceutical productsWholesale of pharmaceutical goods
S

STAR PHARMACEUTICALS LIMITED

Manufacture of basic pharmaceutical products

Founded 16 Feb 2000 Active Harrow, England 0 employees website.com
Manufacture of basic pharmaceutical productsWholesale of pharmaceutical goods
Accounts Submitted 15 Apr 2026 Next due 30 Mar 2026 2 months overdue
Confirmation Submitted 24 Feb 2026 Next due 2 Mar 2027 10 months remaining
Net assets £-433K £384K 2023 year on year
Total assets £84K £4M 2023 year on year
Total Liabilities £516K £4M 2023 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

5 Sandridge Close Harrow Middlesex HA1 1XD England

Full company profile for STAR PHARMACEUTICALS LIMITED (03926727), an active company based in Harrow, England. Incorporated 16 Feb 2000. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Balance Sheet & P&L (2013–2023)

Cash in Bank

£879.00

Decreased by £5.26k (-86%)

Net Assets

-£432.88k

Decreased by £384.16k (-789%)

Total Liabilities

£516.40k

Decreased by £3.98M (-89%)

Turnover

N/A

Employees

N/A

Debt Ratio

618%

Increased by 517 (+512%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

3vs Uk Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Mr Anuj Somchand Bhagwanji Shah

British

Active
Notified 6 Apr 2016
Residence England
DOB November 1966
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 Apr 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/03/25
15 Apr 2026AccountsAnnual accounts filed
15 Apr 2026AccountsAnnual accounts made up to 31 Mar 2025
15 Apr 2026OtherNotice of agreement to exemption from audit of accounts for period ending 31/03/25
24 Feb 2026Confirmation StatementConfirmation statement made on 16 Feb 2026 with no updates
15 Apr 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/03/25

15 Apr 2026 Accounts

Annual accounts filed

15 Apr 2026 Accounts

Annual accounts made up to 31 Mar 2025

15 Apr 2026 Other

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

24 Feb 2026 Confirmation Statement

Confirmation statement made on 16 Feb 2026 with no updates

Recent Activity

Latest Activity

Audit exemption statement of guarantee by parent company for period ending 31/03/25

2 weeks ago on 15 Apr 2026

Annual accounts filed

2 weeks ago on 15 Apr 2026

Annual accounts made up to 31 Mar 2025

2 weeks ago on 15 Apr 2026

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

2 weeks ago on 15 Apr 2026

Confirmation statement made on 16 Feb 2026 with no updates

2 months ago on 24 Feb 2026